|
| | Publication Year | Title | Author(s) |
| 241 | 10-Jun-2020 | Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC. | Samuel, Evangeline; Lie, Gabrielle ; Balasubramanian, Adithya ; Hiong, Alison; So, Yeojeong; Voskoboynik, Mark; Moore, Maggie; Shackleton, Mark; Haydon, Andrew; John, Tom; Mitchell, Paul L R ; Markman, Ben; Briggs, Peter; Parakh, Sagun |
| 242 | Jan-2022 | Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort study. | Lin, Tiffany; Pham, Jonathan; Paul, Eldho; Conron, Matthew; Wright, Gavin; Ball, David; Mitchell, Paul L R ; Atkin, Nicola; Brand, Margaret; Zalcberg, John; Stirling, Robert G |
| 243 | 30-Jan-2024 | Implementation of a nurse-led, multidisciplinary model of care for older adults with cancer: a process evaluation protocol. | Dufton, Polly Hypatia; Tarasenko, Elena; Midgley, Katrina; Lee, Kathryn; Kelly, Ray; Rodrigues, Jeremy; Yates, Paul A ; Arulananda, Surein; Parakh, Sagun |
| 244 | Mar-2023 | In colon cancer cells fascin1 regulates adherens junction remodeling. | Esmaeilniakooshkghazi, Amin; Pham, Eric; George, Sudeep P; Ahrorov, Afzal; Villagomez, Fabian R; Byington, Michael; Mukhopadhyay, Srijita; Patnaik, Srinivas; Conrad, Jacinta C; Naik, Monali; Ravi, Saathvika; Tebbutt, Niall C ; Mooi, Jennifer K ; Reehorst, Camilla M; Mariadason, John M ; Khurana, Seema |
| 245 | Feb-2018 | In Reply to Leone. | Do, Hongdo; Arulananda, Surein; John, Thomas ; Dobrovic, Alexander |
| 246 | Sep-2016 | In vitro and in vivo evaluation of 89Zr-DS-8273a as a theranostic for anti-death receptor 5 therapy | Burvenich, Ingrid JG; Lee, Fook-Thean; Guo, Nancy; Gan, Hui K ; Rigopoulos, Angela; Parslow, Adam C; O'Keefe, Graeme J; Gong, Sylvia J; Tochon-Danguy, Henri J ; Rudd, Stacey E; Donnelly, Paul S; Kotsuma, Masakatsu; Ohtsuka, Toshiaki; Senaldi, Giorgio; Scott, Andrew M |
| 67 | 2016 | Inclusion of elderly patients in oncology clinical trials. | Le Saux, O; Falandry, C; Gan, Hui K ; You, B; Freyer, G; Péron, J |
| 68 | 10-Nov-2014 | Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database. | Shi, Qian; de Gramont, Aimery; Grothey, Axel; Zalcberg, John; Chibaudel, Benoist; Schmoll, Hans-Joachim; Seymour, Matthew T; Adams, Richard A; Saltz, Leonard; Goldberg, Richard M; Punt, Cornelis J A; Douillard, Jean-Yves; Hoff, Paulo M; Hecht, Joel Randolph; Hurwitz, Herbert; Díaz-Rubio, Eduardo; Porschen, Rainer; Tebbutt, Niall C ; Fuchs, Charles; Souglakos, John; Falcone, Alfredo; Tournigand, Christophe; Kabbinavar, Fairooz F; Heinemann, Volker; Van Cutsem, Eric; Bokemeyer, Carsten; Buyse, Marc; Sargent, Daniel J |
| 69 | Jan-2021 | Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma. | Balasubramanian, Adithya ; Gunjur, Ashray ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K |
| 70 | May-2023 | Inside out? An appendix demonstrating adult sequelae of paediatric problems. | Wong, Samantha; Mohan, Helen; Das, Atandrila; Burgess, Adele N ; Proud, David ; Smart, Philip J |
| 71 | 22-Feb-2023 | INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG). | Lam, Lyn Ley; Pavlakis, Nick; Shitara, Kohei; Sjoquist, Katrin M; Martin, Andrew J; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Chen, Li-Tzong; Moehler, Markus; Bekaii-Saab, Tanios; Alcindor, Thierry; O'Callaghan, Christopher J ; Tebbutt, Niall C ; Hague, Wendy; Chan, Howard; Rha, Sun Young; Lee, Keun-Wook; Gebski, Val; Jaworski, Anthony; Zalcberg, John; Price, Timothy; Simes, John; Goldstein, David |
| 72 | 2018 | Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. | Elander, N O; Aughton, K; Ghaneh, P; Neoptolemos, J P; Palmer, D H; Cox, T F; Campbell, F; Costello, E; Halloran, C M; Mackey, J R; Scarfe, A G; Valle, J W; McDonald, A C; Carter, R; Tebbutt, Niall C ; Goldstein, D; Shannon, J; Dervenis, C; Glimelius, B; Deakin, M; Charnley, R M; Anthoney, A; Lerch, M M; Mayerle, J; Oláh, A; Büchler, M W; Greenhalf, W |
| 73 | Jun-2021 | Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study. | Pires da Silva, Ines; Ahmed, Tasnia; Reijers, Irene L M; Weppler, Alison M; Betof Warner, Allison; Patrinely, James Randall; Serra-Bellver, Patricio; Allayous, Clara; Mangana, Joanna; Nguyen, Khang; Zimmer, Lisa; Trojaniello, Claudia; Stout, Dan; Lyle, Megan; Klein, Oliver ; Gerard, Camille L; Michielin, Olivier; Haydon, Andrew; Ascierto, Paolo A; Carlino, Matteo S; Lebbe, Celeste; Lorigan, Paul; Johnson, Douglas B; Sandhu, Shahneen; Lo, Serigne N; Blank, Christian U; Menzies, Alexander M; Long, Georgina V |
| 74 | Aug-2021 | Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' reply. | da Silva, Ines Pires; Ahmed, Tasnia; Reijers, Irene L M; Warner, Allison Betof; Patrinely, James Randall; Serra-Bellver, Patricio; Allayous, Clara; Mangana, Joanna; Zimmer, Lisa; Trojaniello, Claudia; Klein, Oliver ; Gerard, Camille L; Michielin, Olivier; Haydon, Andrew; Ascierto, Paolo A; Carlino, Matteo S; Lebbe, Celeste; Lorigan, Paul; Johnson, Douglas B; Sandhu, Shahneen; Lo, Serigne N; Menzies, Alexander M; Long, Georgina V |
| 75 | Apr-2017 | Is Mesothelioma in China Rare or Misdiagnosed? | John, Thomas ; Russell, Prudence A; Thapa, Bibhusal |
| 76 | 1-Apr-2023 | Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers? | Klein, Oliver ; Kee, Damien ; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Behren, Andreas; Palmer, Jodie ; Tebbutt, Niall C ; Carlino, Matteo S; Cebon, Jonathan S |
| 77 | Sep-2017 | K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines. | Yeung, Yvonne; Lau, David K ; Chionh, Fiona; Tran, Hoanh; Tse, Janson W T; Weickhardt, Andrew J ; Nikfarjam, Mehrdad ; Scott, Andrew M ; Tebbutt, Niall C ; Mariadason, John M |
| 78 | 8-Apr-2022 | 'Know thyself'- host factors influencing cancer response to immune checkpoint inhibitors. | Gunjur, Ashray ; Manrique-Rincón, Andrea J; Klein, Oliver ; Behren, Andreas; Lawley, Trevor D; Welsh, Sarah J; Adams, David J |
| 79 | 1-Aug-1999 | KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma. | Clarke, K; Basser, R L; Underhill, C; Mitchell, Paul L R ; Bartlett, John; Cher, Lawrence M ; Findlay, M; Dalley, D; Pell, M; Byrne, M; Geldard, H; Hill, J S; Maher, D; Fox, R M; Green, M D; Kaye, A H |
| 80 | 2016 | L-Tyrosine confers residualizing properties to a d-Amino acid-rich residualizing peptide for radioiodination of internalizing antibodies | Lee, Fook T; Burvenich, Ingrid JG; Guo, Nancy; Kocovski, Pece; Tochon-Danguy, Henri; Ackermann, Uwe ; O’Keefe, Graeme J; Gong, Sylvia; Rigopoulos, Angela; Liu, Zhanqi; Gan, Hui K ; Scott, Andrew M |
